Charles Jordan, MD
Orthopaedic Surgery · Miami, FLNPI 1114122249
Payments from drug & device makers
What this record shows
The money is spread across several categories — royalties or licence payments (35.4%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. Arthrex accounts for 85.9% of it on its own, with 33 other manufacturers making up the rest. Reporting peaked in 2021 at $335,669 and has fallen 62.6% since, to $125,599 in 2025. Among orthopaedic surgery clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 517 payments — averaging $1580.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$702K
- Advanced Orthopaedic Solutions, Inc.$86K
- Medical Device Business Services, Inc.$22K
- Depuy Synthes Products, Inc.$2K
- Southern Edge Orthopaedics, Inc.$1K
- Johnson & Johnson$1K
- plus $3K from 28 others
What the payments were for
- Royalty or licence$289,00535%
- Consulting fees$219,89727%
- Speaking & faculty fees$258,92632%
- Travel & lodging$25,9233%
- Food & beverage$11,4421%
- Education$11,9351%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 351 | $701,790 |
| Advanced Orthopaedic Solutions, Inc. | 34 | $85,585 |
| Medical Device Business Services, Inc. | 23 | $21,782 |
| Depuy Synthes Products, Inc. | 2 | $2,478 |
| Southern Edge Orthopaedics, Inc. | 6 | $1,398 |
| Johnson & Johnson(2 entities) | 16 | $1,043 |
| Smith+Nephew | 13 | $828 |
| Amgen(2 entities) | 17 | $508 |
| Radius Health, Inc. | 12 | $254 |
| Embody, Inc. | 2 | $213 |
| Stryker | 3 | $182 |
| Bioventus LLC | 9 | $161 |
| DJO, LLC | 4 | $118 |
| Pinnacle, Inc | 1 | $104 |
| Nuvasive Specialized Orthopedics, Inc. | 1 | $80 |
| Zimmer Biomet | 1 | $67 |
| Sanara Medtech Inc. | 2 | $58 |
| Si-bone, Inc. | 2 | $53 |
| Piedmont Plus Innovation | 1 | $52 |
| Aroa Biosurgery Incorporated | 3 | $49 |
| Biom'up France SAS | 1 | $48 |
| Shoulder Innovations, Inc. | 1 | $37 |
| Tactile Systems Technology Inc | 1 | $33 |
| Biotissue Holdings Inc. | 1 | $25 |
| GE HealthCare | 1 | $21 |
| Kerecis Limited | 1 | $20 |
| Electronic Waveform Lab, Inc. | 1 | $20 |
| Solventum Corporation | 1 | $19 |
| Acumed LLC | 1 | $19 |
| Orthofix Medical, Inc. | 1 | $19 |
| Integra Lifesciences Corporation | 1 | $18 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
| Bonalive Inc | 1 | $14 |
| Flower Orthopedics Coporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AOS PRODUCTS$55,127
- NA$23,876
- Trochanteric Nail$21,100
- ARTHREX$16,413
- ALPHA PROXIMAL HUMERAL PLATING SYSTEM$9,087
- TFN ADVANCED$8,039
- TFN-Advance$7,741
- ORTHOPEDIC CABLE / PERIPROSTHETIC SYSTEM$5,758
- IM NAILS$5,533
- DISTAL EXTREMITIES IMPLANTS TRAUMA MINI FRAGMENT$2,738
- SHOULDER IMPLANTS OTHER CLAVICLE FRACTURE$850
- DISTAL EXTREMITIES IMPLANTS FOOT & ANKLE MTP$425
- DISTAL EXTREMITIES IMPLANTS TRAUMA PATELLA FRACTURE$425
- SHOULDER IMPLANTS OTHER AC JOINT REPAIR$425
- DHS$225
- RENASYS TOUCH$212
- PICO 14$212
- DISTAL EXTREMITIES IMPLANTS TIGHTROPE SYNDESMOSIS TIGHTROPES$200
- DISTAL EXTREMITIES IMPLANTS TRAUMA CLAVICLE FRACTURE$200
- PROXIMAL HUMERAL PLATING SYSTEM$155
How this compares
$817,128 in reported general payments places this provider in the 95th percentile of 1,263 orthopaedic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 105 | $1,922 |
| Meloxicam | 129 | $393 |
| Naproxen | 26 | $221 |
| Tramadol Hcl | 32 | $112 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 15 | $94 |
| Amoxicillin | 19 | $77 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Miami
- Charles LawrieMiami$1.7M
- Rolando GarciaMiami$1M
- Francis HornicekMiami$790K
- Aldo RiesgoMiami$709K
- Andrew CooperClearwater$102M
- Richard HynesMelbourne$34.8M
- Mark FrankleTemple Terrace$31M
- Roy SandersTemple Terrace$19.6M
- George HaidukewychOrlando$10M
- Robert SantrockFernandina Beach$7.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.